Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations and Comprehensive Loss

v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue $ 17,925 $ 18,279
Cost of revenue 8,414 9,200
Gross profit 9,511 9,079
Operating expenses:    
Sales and marketing 7,308 8,472
Research and development 3,874 5,025
General and administrative 8,789 10,694
Total operating expenses 19,971 24,191
Loss from operations (10,460) (15,112)
Other (expense) income, net:    
Interest expense, net (269) (302)
Gain (loss) on revaluation of warrant liabilities 474 (133)
Loss on modification of warrant (109) 0
Unrealized (loss) gain on foreign exchange (965) 412
Other expense, net (1) (63)
Total other (expense) income, net (870) (86)
Net loss (11,330) (15,198)
Foreign currency translation adjustments 801 (407)
Comprehensive loss $ (10,529) $ (15,605)
Net loss per share applicable to common shareholders, basic and diluted (in dollars per share) $ (0.56) $ (1.1)
Weighted average number of shares outstanding, basic and diluted (in shares) [1] 20,161 13,867
[1] Includes the weighted average effect of the Pre-Funded Warrant, the exercise of which requires nominal consideration for the delivery of the shares of common stock.